Amneal Pharmaceuticals · 1 day ago
Quality Assurance Inspector - 2nd Shift
Amneal Pharmaceuticals is seeking a Quality Assurance Inspector to ensure compliance with established specifications for raw materials and packaging components. The role involves monitoring drug manufacturing processes, conducting inspections, and maintaining detailed records of quality assurance activities.
ManufacturingMedicalPharmaceutical
Responsibilities
Perform inspection, sampling, and testing of incoming raw materials, packaging components, and returned goods per written procedures
Prepare samples for chemical and microbiological analysis and deliver them to the QC lab
Inspect and test packaging components using measuring devices (e.g., scales, micrometers, height gauges) to ensure specification compliance
Maintain detailed records of all sampling, inspection, and testing activities
Assign and verify expiry and retest dates for GMP raw materials using vendor and in-house Certificates of Analysis (COA)
Collect packaged product samples for annual stability studies
Conduct room, equipment, and packaging line checks before each manufacturing stage
Perform in-process testing as per manufacturing and packaging batch record instructions
Prepare finished product samples for QC lab and QA retains, following documentation protocols
Maintain standard weights for daily balance verification
Label component receipt: visual examination, counting, preliminary inspection, and sampling
Prepare inspection reports for labeling components/outserts; manage quarantine and release labels, and maintain logs and inventory cards
Issue labeling components/outserts per packaging orders; monitor and audit label room activities
Complete QA final labeled product inspection reports and final line clearance, including reconciliation paperwork
Ensure warehouse compliance: proper isolation of Quarantine, Released, In-Process, Finished, Packaged, Returned, and Rejected goods
Isolate and document rejected materials during batch processes, ensuring accountability in batch records
Monitor facility and product environmental operating conditions
Operate, maintain and calibrate Hardness tester, Fibrillatory, Weight Variation system, weighing scales and balances, label counting machine, and Kirby Lester tablet counters according to established schedules and maintain detailed calibration records
Collection of samples to reassay bulk finished product before expiration
Work in a Contained Manufacturing area/facility following all precautions and procedures
Visual inspection and preparation of report of all products for APR
Other duties as assigned by management
Qualification
Required
High School or GED - Required
1 year in QA or related field
High energy level and organizational skills. - Advanced
A certain degree of creativity and latitude is required. - Intermediate
Basic computer skills (Word and Excel ) - Intermediate
Good basic math knowledge and excellent attention to details
Records observations for improving processes
Benefits
Short-term incentive opportunity, such as a bonus or performance-based award
Long-term incentive award, such as restricted stock units
Comprehensive, flexible and competitive benefits program
Above-market, diverse and robust health and insurance benefits
Significant 401(k) matching contribution
Programs that help you enjoy your career alongside life’s many other commitments and opportunities
Company
Amneal Pharmaceuticals
Amneal Pharmaceuticals manufactures, markets and/or distributes more than 88 drugs in the United States.
H1B Sponsorship
Amneal Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (25)
2024 (32)
2023 (33)
2022 (33)
2021 (42)
2020 (34)
Funding
Current Stage
Public CompanyTotal Funding
$3.2B2023-11-16Post Ipo Debt· $2.35B
2018-05-07IPO
2017-10-01Post Ipo Equity· $854M
Recent News
Morningstar.com
2025-12-24
2025-12-24
MarketScreener
2025-12-24
Company data provided by crunchbase